This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Boehringer Ingelheim Animal Health USA Inc., Sanofi. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2019
Title: Innovations by Inventor Michel Partiseti
Introduction
Michel Partiseti is a notable inventor based in Bourg la Reine, France. He has made significant contributions to the field of biotechnology, particularly in the development of mammalian cell lines for high-throughput screening assays. With one patent to his name, Partiseti has demonstrated his innovative approach to addressing challenges in pharmaceutical research.
Latest Patents
Michel Partiseti's patent, titled "Mammalian cell lines expressing functional nematode acetylcholine receptors and use thereof for high-throughput screening assays," discloses a novel approach to utilizing mammalian cell lines that stably express functional nematode acetylcholine receptor subunits. The stable co-expression of the chaperone protein RIC3 facilitates the expression of functional ion channels, which are essential for conducting high-throughput screening of compounds. This innovative method is particularly useful for identifying new candidate parasiticidal and nematocidal active ingredients.
Career Highlights
Throughout his career, Michel Partiseti has worked with esteemed organizations in the pharmaceutical industry, including Boehringer Ingelheim Animal Health, Inc. and Sanofi. His work in these companies has involved research and development efforts that have propelled advancements in animal health and drug discovery.
Collaborations
Partiseti has collaborated with noteworthy colleagues such as Lance Hammerland and Brenda Bondesen. These partnerships have played a vital role in enhancing the collaborative nature of research in his projects, leading to more comprehensive and effective outcomes.
Conclusion
Michel Partiseti stands out as an innovative inventor who has made strides in biotechnology through his patented work. His developments in mammalian cell lines and high-throughput screening assays highlight the potential for significant advancements in the pharmaceutical sector. The collaborations and achievements of Partiseti exemplify the impact that dedicated inventors can have on improving health outcomes and advancing scientific knowledge.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile